Danubian Biobank konzorcium

A duna menti egyetemek "biobanking" tevékenységének összehangolása

Translated title of the contribution: The Danubian Biobank initiative: Synchronizing the biobanking activities of the Danube universities

Research output: Contribution to journalArticle

Abstract

Aging disorders pose an increasing challenge for the public health care systems in Europe. An important approach to cope with this task is the identification of relevant novel disease genes and the control of risk factors using new technological capabilities. A key element in this process is the availability of well classified, large enough patient cohorts and the establishment of quality-controlled central banks for DNA, serum, plasma, and cells/tissues/RNA/proteins together with the development of an IT based infrastructure to provide samples and data required for biomedical studies. The Danubian Biobank initiative connects universities, associated teaching hospitals and endpoint-related rehabilitation clinics along the Danube river and in neighbouring regions. The scientific network focuses on diabetes-related endpoints, vascular disease (e.g. myocardial infarction, stroke, arterial thrombosis, kidney failure), metabolic disease (e.g. obesity, diabetes, metabolic syndrome), and neurodegenerative disorders (e.g. dementia syndromes, Parkinsonism). Task forces are set up for the relevant topics of the biobank project including patient recruitment, sample and data management, public health, epidemiology and genetics, enabling technologies, and research strategies. The project aims to select the most relevant and promising scientific targets utilizing the core competences developed in the individual partner institutions. For this purpose a series of dedicated workshops and conferences are organized as well as joint research grant proposals are submitted.

Original languageHungarian
Pages (from-to)1999-2002
Number of pages4
JournalOrvosi Hetilap
Volume148
Issue number42
DOIs
Publication statusPublished - Oct 21 2007

Fingerprint

Public Health
Molecular Epidemiology
Organized Financing
Metabolic Diseases
Parkinsonian Disorders
Advisory Committees
Plasma Cells
Vascular Diseases
Rivers
Teaching Hospitals
Neurodegenerative Diseases
Mental Competency
Patient Selection
Renal Insufficiency
Dementia
Thrombosis
Research Design
Rehabilitation
Obesity
Stroke

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{ad40431dd4fd44c88d279b593153f52a,
title = "Danubian Biobank konzorcium: A duna menti egyetemek {"}biobanking{"} tev{\'e}kenys{\'e}g{\'e}nek {\"o}sszehangol{\'a}sa",
abstract = "Aging disorders pose an increasing challenge for the public health care systems in Europe. An important approach to cope with this task is the identification of relevant novel disease genes and the control of risk factors using new technological capabilities. A key element in this process is the availability of well classified, large enough patient cohorts and the establishment of quality-controlled central banks for DNA, serum, plasma, and cells/tissues/RNA/proteins together with the development of an IT based infrastructure to provide samples and data required for biomedical studies. The Danubian Biobank initiative connects universities, associated teaching hospitals and endpoint-related rehabilitation clinics along the Danube river and in neighbouring regions. The scientific network focuses on diabetes-related endpoints, vascular disease (e.g. myocardial infarction, stroke, arterial thrombosis, kidney failure), metabolic disease (e.g. obesity, diabetes, metabolic syndrome), and neurodegenerative disorders (e.g. dementia syndromes, Parkinsonism). Task forces are set up for the relevant topics of the biobank project including patient recruitment, sample and data management, public health, epidemiology and genetics, enabling technologies, and research strategies. The project aims to select the most relevant and promising scientific targets utilizing the core competences developed in the individual partner institutions. For this purpose a series of dedicated workshops and conferences are organized as well as joint research grant proposals are submitted.",
keywords = "Biobanking, Metabolic diseases, Networking, Neurodegenerative diseases, Vascular diseases",
author = "B. Gy{\"o}rffy and L. Rosivall and Z. Proh{\'a}szka and A. Falus and G. F{\"u}st and Gy{\"o}ngyi Munk{\'a}csy and T. Tulassay",
year = "2007",
month = "10",
day = "21",
doi = "10.1556/OH.2007.28066",
language = "Hungarian",
volume = "148",
pages = "1999--2002",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "42",

}

TY - JOUR

T1 - Danubian Biobank konzorcium

T2 - A duna menti egyetemek "biobanking" tevékenységének összehangolása

AU - Györffy, B.

AU - Rosivall, L.

AU - Prohászka, Z.

AU - Falus, A.

AU - Füst, G.

AU - Munkácsy, Gyöngyi

AU - Tulassay, T.

PY - 2007/10/21

Y1 - 2007/10/21

N2 - Aging disorders pose an increasing challenge for the public health care systems in Europe. An important approach to cope with this task is the identification of relevant novel disease genes and the control of risk factors using new technological capabilities. A key element in this process is the availability of well classified, large enough patient cohorts and the establishment of quality-controlled central banks for DNA, serum, plasma, and cells/tissues/RNA/proteins together with the development of an IT based infrastructure to provide samples and data required for biomedical studies. The Danubian Biobank initiative connects universities, associated teaching hospitals and endpoint-related rehabilitation clinics along the Danube river and in neighbouring regions. The scientific network focuses on diabetes-related endpoints, vascular disease (e.g. myocardial infarction, stroke, arterial thrombosis, kidney failure), metabolic disease (e.g. obesity, diabetes, metabolic syndrome), and neurodegenerative disorders (e.g. dementia syndromes, Parkinsonism). Task forces are set up for the relevant topics of the biobank project including patient recruitment, sample and data management, public health, epidemiology and genetics, enabling technologies, and research strategies. The project aims to select the most relevant and promising scientific targets utilizing the core competences developed in the individual partner institutions. For this purpose a series of dedicated workshops and conferences are organized as well as joint research grant proposals are submitted.

AB - Aging disorders pose an increasing challenge for the public health care systems in Europe. An important approach to cope with this task is the identification of relevant novel disease genes and the control of risk factors using new technological capabilities. A key element in this process is the availability of well classified, large enough patient cohorts and the establishment of quality-controlled central banks for DNA, serum, plasma, and cells/tissues/RNA/proteins together with the development of an IT based infrastructure to provide samples and data required for biomedical studies. The Danubian Biobank initiative connects universities, associated teaching hospitals and endpoint-related rehabilitation clinics along the Danube river and in neighbouring regions. The scientific network focuses on diabetes-related endpoints, vascular disease (e.g. myocardial infarction, stroke, arterial thrombosis, kidney failure), metabolic disease (e.g. obesity, diabetes, metabolic syndrome), and neurodegenerative disorders (e.g. dementia syndromes, Parkinsonism). Task forces are set up for the relevant topics of the biobank project including patient recruitment, sample and data management, public health, epidemiology and genetics, enabling technologies, and research strategies. The project aims to select the most relevant and promising scientific targets utilizing the core competences developed in the individual partner institutions. For this purpose a series of dedicated workshops and conferences are organized as well as joint research grant proposals are submitted.

KW - Biobanking

KW - Metabolic diseases

KW - Networking

KW - Neurodegenerative diseases

KW - Vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=35648974770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648974770&partnerID=8YFLogxK

U2 - 10.1556/OH.2007.28066

DO - 10.1556/OH.2007.28066

M3 - Article

VL - 148

SP - 1999

EP - 2002

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 42

ER -